OverviewChartNewsTraderScreen

DZ Bank Call 230 BNTX 21.06.2024/  DE000DW7F7C1  /

EUWAX
5/31/2024  9:50:03 PM Chg.0.000 Bid10:00:41 PM Ask10:00:41 PM Underlying Strike price Expiration date Option type
0.001EUR 0.00% -
Bid Size: -		 -
Ask Size: -		 BioNTech SE 230.00 USD 6/21/2024 Call
GlobeNewswire 5/29 BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
GlobeNewswire 5/28 Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology ...
GlobeNewswire 5/21 BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...
GlobeNewswire 5/21 Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...
GlobeNewswire 5/17 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GlobeNewswire 5/17 Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
GlobeNewswire 5/9 Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
TeleTrader 5/6 BioNTech's Q1 revenue slumps 85% to €187.6M
GlobeNewswire 5/6 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
TeleTrader 5/6 Europe mixed premarket with data on the limelight
GlobeNewswire 5/2 Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 4/22 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire 4/10 Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first...
GlobeNewswire 4/7 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
GlobeNewswire 4/4 Medigene AG Secures European Patent for its iM-TCR Technology
GlobeNewswire 3/28 Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 3/27 Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
TeleTrader 3/20 BioNTech Q4 revenue plunges 65% to €1.48B
GlobeNewswire 3/20 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 3/20 BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
TeleTrader 3/20 Europe mixed premarket amid data
GlobeNewswire 3/14 Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
GlobeNewswire 3/12 The Gross Law Firm Notifies BioNTech SE Investors of a Class Action Lawsuit and Upcoming Deadline – ...
GlobeNewswire 3/11 BNTX DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Co...
GlobeNewswire 3/11 FINAL DEADLINE REMINDER FOR BNTX INVESTORS: Kessler Topaz Meltzer & Check, LLP Announces Final Lead ...